BR112018077219A2 - matriz de peptídeo de automontagem para a prevenção de estenose esofágica após dissecção endoscópica - Google Patents

matriz de peptídeo de automontagem para a prevenção de estenose esofágica após dissecção endoscópica

Info

Publication number
BR112018077219A2
BR112018077219A2 BR112018077219-4A BR112018077219A BR112018077219A2 BR 112018077219 A2 BR112018077219 A2 BR 112018077219A2 BR 112018077219 A BR112018077219 A BR 112018077219A BR 112018077219 A2 BR112018077219 A2 BR 112018077219A2
Authority
BR
Brazil
Prior art keywords
prevention
self
assembling peptide
esophageal stenosis
esophageal
Prior art date
Application number
BR112018077219-4A
Other languages
English (en)
Portuguese (pt)
Inventor
Seok Gil Eun
Reveiller-Buffier Marie
Prat Frederic
Louis François Benjamin Barret Maximilien
Original Assignee
3-D Matrix, Ltd.
Assistance Publique-Hopitaux De Paris (Ap-Hp)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3-D Matrix, Ltd., Assistance Publique-Hopitaux De Paris (Ap-Hp) filed Critical 3-D Matrix, Ltd.
Publication of BR112018077219A2 publication Critical patent/BR112018077219A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10Peptides having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/267Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the respiratory tract, e.g. laryngoscopes, bronchoscopes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1858Platelet-derived growth factor [PDGF]
    • A61K38/1866Vascular endothelial growth factor [VEGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Vascular Medicine (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112018077219-4A 2016-06-27 2017-06-27 matriz de peptídeo de automontagem para a prevenção de estenose esofágica após dissecção endoscópica BR112018077219A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662355111P 2016-06-27 2016-06-27
US62/355,111 2016-06-27
PCT/US2017/039407 WO2018005427A1 (en) 2016-06-27 2017-06-27 Self-assembling peptide matrix for the prevention of esophageal stricture after endoscopic dissection

Publications (1)

Publication Number Publication Date
BR112018077219A2 true BR112018077219A2 (pt) 2019-04-09

Family

ID=59295359

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018077219-4A BR112018077219A2 (pt) 2016-06-27 2017-06-27 matriz de peptídeo de automontagem para a prevenção de estenose esofágica após dissecção endoscópica

Country Status (8)

Country Link
US (1) US20190358290A1 (https=)
EP (1) EP3474880A1 (https=)
JP (2) JP2019518569A (https=)
CN (1) CN109996553A (https=)
AU (1) AU2017289150A1 (https=)
BR (1) BR112018077219A2 (https=)
CA (1) CA3029455A1 (https=)
WO (1) WO2018005427A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2966711T3 (es) 2018-06-21 2024-04-23 Univ Pittsburgh Commonwealth Sys Higher Education Hidrogel de matriz extracelular (ECM) como almohadilla líquida submucosa
CN115444993B (zh) * 2018-06-21 2024-03-29 联邦高等教育系统匹兹堡大学 细胞外基质(ecm)水凝胶作为食管粘膜下流体垫的用途
CN115671410B (zh) 2018-06-21 2024-06-18 联邦高等教育系统匹兹堡大学 膀胱ecm水凝胶作为食管粘膜下层流体垫的用途
WO2021202577A1 (en) 2020-03-31 2021-10-07 3-D Matrix, Ltd. Sterilization of self-assembling peptides by irradiation
RU2751285C1 (ru) * 2020-07-22 2021-07-12 Федеральное государственное бюджетное научное учреждение "Российский научный центр хирургии имени академика Б.В. Петровского" Способ хирургического лечения стриктур пищеводных анастомозов

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050245788A1 (en) * 2004-04-28 2005-11-03 Medtronic, Inc. Esophageal delivery system and method with position indexing
US9162005B2 (en) * 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
JP5263756B2 (ja) * 2005-09-30 2013-08-14 国立大学法人 岡山大学 細胞の培養方法および細胞培養物
US20150105336A1 (en) * 2012-03-09 2015-04-16 3-D Matrix, Ltd. Mucosa-elevating agent
BR112015022747B1 (pt) * 2013-03-14 2020-10-13 3-D Matrix, Ltd kit para prevenção de estenose e uso de um peptídeo de automontagem
AU2015229549B2 (en) * 2014-03-10 2019-05-23 3-D Matrix, Ltd. Self-assembling peptide compositions

Also Published As

Publication number Publication date
JP2022023249A (ja) 2022-02-07
AU2017289150A1 (en) 2019-01-24
CN109996553A (zh) 2019-07-09
US20190358290A1 (en) 2019-11-28
WO2018005427A1 (en) 2018-01-04
EP3474880A1 (en) 2019-05-01
JP2019518569A (ja) 2019-07-04
CA3029455A1 (en) 2018-01-04

Similar Documents

Publication Publication Date Title
BR112018077219A2 (pt) matriz de peptídeo de automontagem para a prevenção de estenose esofágica após dissecção endoscópica
BR112015022747A8 (pt) kit para prevenção de estenose e uso de um peptídeo de automontagem
MX2015008226A (es) Metodos para modular la homeostasis de los acidos biliares, y tratamiento de trastornos y enfermedades causadas por los acidos biliares.
EA201792307A1 (ru) Способы репарации и регенерации тканей
EA201490735A1 (ru) Лечение дегенеративного заболевания сустава
MX373656B (es) Compuestos de 1-ciano-pirrolidina como inhibidores de las enzimas desubiquitinantes, como la hidrolasa 30 de la c-terminal de la ubiquitina (usp30), y el uso de los mismos en el tratamiento de condiciones de disfunción mitocondrial y tratamiento de cancér.
MX376835B (es) Inhibidores de lisil oxidasa tipo 2 fluorinados y usos de los mismos.
UY33826A (es) Proteínas de unión con dominios trivariables y sus usos
ECSP11010810A (es) Anticuerpos monoclonales contra el inhibidor de la vía del factor tisular (tfpi)
BR112017015833A2 (pt) compostos anti-senescência e usos dos mesmos
AR088392A1 (es) Macrociclos peptidomimeticos
CU20120126A7 (es) Anticuerpos monoclonales optimizados contra el inhibidor de la vía del factor tisular (tfpi)
WO2017178883A8 (en) Treatment of idiopathic pulmonary fibrosis using rna complexes that target connective tissue growth factor
EA201200515A1 (ru) Полипептиды и их применение
ES2688030T3 (es) Péptidos permeables celulares inhibidores de la ruta de transducción de la señal JNK para su uso en el tratamiento de enfermedades oculares inflamatorias
HK1220145A1 (zh) 胆漏治疗
DE602005015973D1 (de) Gewebeinhibitor für Metalloproteinasen (TIMP) gebunden an ein Glycosylphosphatidylinositol (GPI-) Anker zur Behandlung von Krebs
PE20170955A1 (es) Nuevas proteinas inhibidoras de insectos
CY1125043T1 (el) Ενωση τριπεπτιδιο, μεθοδος παρασκευης αυτης, και εφαρμογη αυτης
UY38352A (es) Inhibidores de integrina alfavbeta6
MX2016012248A (es) Composiciones para el tratamiento de autodigestion.
BR112019003915A2 (pt) composição para tratamento dos cabelos, método de tratamento de cabelo danificado quimicamente e usos de uma composição
EA201692038A1 (ru) Способы и композиции для лечения сосудистой мальформации
MX2017008994A (es) Formulacion de peptidos inhibidores mk2.
MX2018003962A (es) Proceso para producir fosfinatos.

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2676 DE 19-04-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.